Released Nov 3, 2026, after the close
10-Q filed Nov 3, 2026, 34 days after period end · 0001628280-26-069653
What the release said
Curaleaf Holdings, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026, a copy of which is attached as Exhibit 99.1.
Curaleaf reported third quarter 2026 net revenue of $352.7 million, a 10.9% year-over-year increase from $317.9 million in Q3 2025.¶2
The company reported a net loss attributable to Curaleaf from continuing operations of $37.4 million, or $0.14 per share, and adjusted EBITDA of 77.6 million for the quarter.¶3¶4
Curaleaf ended the quarter with total cash and cash equivalents of $104.9 million and repurchased 105,440 shares for a total of $1 million.¶5¶6
Curaleaf commenced an Original Offer to purchase all outstanding common shares of Aurora Cannabis Inc. for SVS and cash, then enhanced the offer and increased the consideration.¶7¶8
- Q3 2026 net revenue
- $352.7 million¶2
- Q3 2026 net loss from continuing operations attributable to Curaleaf
- $37.4 million¶3
- Q3 2026 adjusted EBITDA
- $77.6 million¶9
- Nine months 2026 net revenue
- $1,017.0 million¶10
- Nine months 2026 net income from continuing operations attributable to Curaleaf
- $45.2 million¶11
Same quarter
| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | $352.65M | $317.86M |
| Net Income | -$32.72M | -$57.03M |
| EPS Diluted | -$0.12 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Curaleaf Holdings, Inc. · CIK 1756770 · Engraved from SEC EDGAR